Last Price$2.79NASDAQ Previous Close - Last Trade as of 3:59PM ET 6/04/20

Today's Change+0.07(2.57%)
Bid (Size)$2.81 (4)
Ask (Size)$2.89 (5)
Day Low / High$2.72 - 2.90
Volume618.4 K

Exicure Maintaining R&D Operations Amid COVID-19 Pandemic

7:23AM ET 3/31/2020 MT Newswires
Exicure (XCUR), a clinical-stage biotechnology company, said Monday it continues to conduct research and development activities despite the ongoing COVID-19 pandemic as it has been recognized by the State of Illinois as an "essential" business.

The company still expects the phase 2 stage of its phase 1b/2 trial of AST-008 in patients with advanced or metastatic Merkel cell carcinoma or cutaneous squamous cell carcinoma to begin in Q2.

As of Feb. 29, the company has a cash balance of $107.7 million, it said.


Price: 1.3700, Change: +0.0500, Percent Change: +3.79